CRIS Current Research Information System

CAMPIERI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.968
AS - Asia 8.398
EU - Europa 6.133
Continente sconosciuto - Info sul continente non disponibili 571
SA - Sud America 570
AF - Africa 543
OC - Oceania 22
Totale 27.205
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.706
VN - Vietnam 2.611
SG - Singapore 2.190
CN - Cina 1.780
GB - Regno Unito 1.355
IT - Italia 994
SE - Svezia 828
DE - Germania 758
HK - Hong Kong 607
FR - Francia 442
BR - Brasile 404
RU - Federazione Russa 351
IN - India 350
UA - Ucraina 304
IE - Irlanda 297
JP - Giappone 167
NL - Olanda 156
TG - Togo 139
FI - Finlandia 137
CI - Costa d'Avorio 130
ZA - Sudafrica 117
CA - Canada 116
KR - Corea 110
BG - Bulgaria 100
CH - Svizzera 97
JO - Giordania 93
BD - Bangladesh 92
SC - Seychelles 86
EE - Estonia 84
BE - Belgio 66
PH - Filippine 66
AR - Argentina 64
TH - Thailandia 45
HN - Honduras 40
ID - Indonesia 40
IQ - Iraq 37
MX - Messico 35
PL - Polonia 35
TW - Taiwan 30
ES - Italia 29
EC - Ecuador 28
NG - Nigeria 26
TR - Turchia 26
GR - Grecia 21
IR - Iran 21
PK - Pakistan 21
SA - Arabia Saudita 20
UZ - Uzbekistan 20
AU - Australia 19
CL - Cile 18
JM - Giamaica 18
CO - Colombia 17
MY - Malesia 17
VE - Venezuela 17
BZ - Belize 15
CZ - Repubblica Ceca 13
AT - Austria 12
PY - Paraguay 11
HR - Croazia 10
RO - Romania 9
CR - Costa Rica 8
EG - Egitto 8
ET - Etiopia 8
AE - Emirati Arabi Uniti 7
BH - Bahrain 7
LT - Lituania 7
PT - Portogallo 7
IL - Israele 6
KE - Kenya 6
KZ - Kazakistan 6
MA - Marocco 6
AZ - Azerbaigian 5
BO - Bolivia 5
NI - Nicaragua 5
GT - Guatemala 4
MD - Moldavia 4
PE - Perù 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
BB - Barbados 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
LB - Libano 3
MN - Mongolia 3
NP - Nepal 3
PR - Porto Rico 3
PS - Palestinian Territory 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
BY - Bielorussia 2
LV - Lettonia 2
MT - Malta 2
MU - Mauritius 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
Totale 26.609
Salva come PNG Salva come JPEG
Città #
Singapore 1.508
Ashburn 1.168
Southend 1.110
Chandler 807
Fairfield 763
Hong Kong 566
San Jose 552
Ho Chi Minh City 551
Santa Clara 512
Hanoi 438
Dong Ket 421
Woodbridge 411
Houston 362
Princeton 349
Seattle 334
Wilmington 329
Dublin 294
Ann Arbor 292
Beijing 288
Council Bluffs 281
Cambridge 273
Boardman 191
Hefei 177
Lauterbourg 169
Jacksonville 167
Los Angeles 165
Bologna 160
New York 144
Lomé 139
Abidjan 130
Tokyo 130
Berlin 127
Helsinki 126
Nanjing 124
Westminster 114
Milan 111
Padova 104
Sofia 96
Amman 93
Buffalo 84
Dallas 84
Da Nang 80
Bern 79
Frankfurt am Main 77
Phoenix 77
San Diego 76
Seoul 75
Haiphong 73
Shenyang 64
Turin 57
São Paulo 53
Saint Petersburg 52
Guangzhou 50
Changsha 47
Redondo Beach 45
Washington 44
Hebei 43
Jinan 43
Rome 43
Brussels 42
Nanchang 42
Atlanta 40
Chicago 40
Mülheim 38
London 37
San Francisco 37
Yubileyny 36
Bremen 34
Henderson 34
Medford 34
Montreal 34
Redwood City 34
Shanghai 33
Munich 32
Orem 32
Boston 30
Falkenstein 29
Tianjin 29
Centro 26
Saint Louis 26
Toronto 26
Hải Dương 25
Bengaluru 24
Dearborn 23
Olalla 23
Quận Bình Thạnh 23
Redmond 23
Jiaxing 22
Warsaw 22
Brierley Hill 21
Denver 21
Haikou 21
Zhengzhou 20
Bangkok 19
Brooklyn 19
Can Tho 19
Mahé 19
Nuremberg 19
Taizhou 19
Thái Nguyên 19
Totale 16.468
Salva come PNG Salva come JPEG
Nome #
Refractory Complex Crohn's Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection 697
Ancient pathogen-driven adaptation triggers increased susceptibility to non-celiac wheat sensitivity in present-day European populations 487
Ulcerative Colitis 395
Dietary geraniol ameliorates intestinal dysbiosis and relieves symptoms in irritable bowel syndrome patients: a pilot study. 333
Essential oils as intestinal microbiota regulators in models of mice induced colitis. 328
Acute granulomatous interstitial nephritis and ulcerative colitis: A case report and literature review 314
5-Aminosalicylic acid in patients with ulcerative colitis in remission: plasma levels after administration of a new rectal enema 292
Adult attachment and early parental experiences in patients with Crohn’s Disease 269
5-Aminosalicylic acid suppositories in the management of ulcerative colitis 267
Eicosapentaenoic Acid Reduces Fecal Levels of Calprotectin and Prevents Relapse in Patients With Ulcerative Colitis 262
Can supplementation of phytoestrogens/insoluble fibers help the management of duodenal polyps in familial adenomatous polyposis? 261
Absence of change in the gray matter volume of patients with ulcerative colitis in remission: a voxel based morphometry study 256
Antioxidant, anti-inflammatory, and microbial-modulating activities of essential oils: Implications in colonic pathophysiology 255
Management of pouch dysfunction or pouchitis with an ileoanal pouch. 248
Dietary geraniol by oral or enema administration strongly reduces dysbiosis and systemic inflammation in dextran sulfate sodium-treated mice 246
A-Transducin, a Signaling Molecule of the Chemoreceptive Cascade, Is Expressed in Endocrine and Non-Endocrine Cells of the Pig Gastrointestinal Mucosa 244
Attachment and perceived stress in patients with ulcerative colitis, a case–control study 240
Stress and brain functional changes in patients with Crohn's disease: A functional magnetic resonance imaging study 240
Real-time elastography for the detection of fibrotic and inflammatory tissue in patients with stricturing Crohn's disease 240
Responses of peripheral blood mononucleated cells from non-celiac gluten sensitive patients to various cereal sources 236
Four cases of carcinoid tumour in Crohn's disease: coincidence or correlation? 232
Medical treatment and management of severe ulcerative colitis 228
Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease 228
Distinct proteomic profiles characterise non-erosive from erosive reflux disease. 227
Probiotics, Prebiotics and Antibiotics in the Treatment of Inflammatory Bowel Disease 227
Prevalence and effectiveness of psychiatric treatments for patients with IBD: A systematic literature review 227
Infliximab in the treatment of Crohn's disease 222
Attachment and quality of life in patients with inflammatory bowel disease 220
Attachment and mentalizing abilities in patients with inflammatory bowel disease 220
Clinical management of severe active ulcerative colitis in the TNF-α inhibitors era 220
Short-term treatment with Infliximab in chronic refractory pouchitis and ileitis. 219
High-dose probiotics for the treatment of active pouchitis 217
Influence of steroid treatment's duration in patients with active Crohn's disease 211
MODULATION OF HUMAN DENDRITIC CELL PHENOTYPE AND FUNCTION BY PROBIOTIC BACTERIA 206
Cutaneous Manifestations in Inflammatory Bowel Diseases: Eight Cases of Psoriasis Induced by Anti-Tumor-Necrosis-Factor Antibody Therapy 206
Adalimumab in the Treatment of Perianal Crohn's Disease: A Single Center in 64 Patients 203
Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease 203
Drug delivery by polymeric micelles: an in vitro and in vivo study to deliver lipophilic substances to colonocytes and selectively target inflamed colon 202
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis 199
Functional magnetic resonance imaging study reveals differences in the habituation to psychological stress in patients with Crohn's disease versus healthy controls 197
Brain functional changes in patients with ulcerative colitis: a functional magnetic resonance imaging study on emotional processing 196
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. 194
Clinical course of microscopic colitis in a single-center cohort study 194
Antibiotics and probiotics in treatment of inflammatory bowel disease 194
Alessitimia e stress percepito in 323 pazienti affetti da IBD 192
Oral budesonide in the treatment of chronic refractory pouchitis. 191
Management and treatment of distal ulcerative colitis 191
Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis 190
Management of inflammatory bowel disease: does rifaximin offer any promises 187
Review article: aminosalicylates for distal colitis 187
Loss of miR-101 expression promotes Wnt/β-catenin signalling pathway activation and malignancy in colon cancer cells 187
Parental Bonding and Inflammatory Bowel Disease 187
Role of conventional therapies in the era of biological treatment in Crohn's disease. 185
Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production 183
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: LONG TERM RESULTS IN A SINGLE TERTIARY CENTRE 183
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: A SINGLE CENTER EXPERIENCE IN 64 PATIENTS 181
MANAGEMENT OF POUCHITIS 180
Medical Treatment of Ulcerative Colitis: does traditional therapy still have a role? 179
Comparison of intestinal ultrasound, conventional enteroclysis, CT and MRI enteroclysis, surgical findings for determining complications in patients with Crohn's Disease 179
Selective cyclooxygenase-2 (COX-2) silencing mediated by engineered Escherichia coli and RNA Interference induces anti-tumour effects in human colon cancer cells 178
COMBINATION OF SURGICAL THERAPY AND LOCAL INJECTIONS OF ADALIMUMAB IN TREATEMENT OF COMPLEX PERIANAL CROHN'S DISEASE 177
The role of Budesonide-MMX in active ulcerative colitis. 177
Local Injection of Infliximab for the Treatment of Perianal Crohn's Disease. 176
[Abdominal scintigraphy with leukocytes marked with indium-111 in Crohn disease: clinical importance and prognostic usefulness] 176
Which therapies are advisable in pouchitis? 174
Antimicrobials in the management of inflammatory bowel disease 174
Longitudinal analysis of inflammation and microbiota dynamics in a model of mild chronic dextran sulfate sodium-induced colitis in mice 171
Sporadic small bowel tumors detected by capsule endoscopy in patients with occult gastrointestinal bleeding 170
Sympathetic hyperactivity in patients with ulcerative colitis. 169
OC.01.8 USE OF INFLIXIMAB AND ADALIMUMAB IN REFRACTORY POUCHITIS 169
Randomized controlled trials in pouchitis 169
Topical treatment of distal active ulcerative colitis with beclometasone dipropionato or mesalamine: a single-blind randomized controlled trial 167
Risks and Benefits of Mucosal Healing With Combined Immunosuppression in Paediatric Crohn's Disease: A Complex Topic That Needs Careful Evaluation 167
Combined carriership of TLR9-1237C and CD14-260T alleles enhances the risk of developing chronic relapsing pouchitis 167
VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis 166
Oral beclomethasone dipropionate in chronic refractory pouchitis 166
Eviendep® reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosis 166
New insights into the brain involvement in patients with Crohn's disease: a voxel-based morphometry study 165
Problematic proctitis and distal colitis 165
The role of antibiotics and probiotics in pouchitis 160
null 159
A new oral delivery system for 5-ASA: preliminary clinical findings for MMx 159
CT-guided percutaneous pelvic abscess drainage in Crohn's disease 158
Obscure gastrointestinal bleeding: single centre experience of capsule endoscopy. 158
The safety of beclomethasone dipropionate in the treatment of ulcerative colitis 151
Risk of permanent stoma in extensive Crohn's colitis: The impact of biological drugs 149
Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin 148
RISK OF SHORT TERM POSTOPERATIVE COMPLICATIONS IN PATIENTS TREATED WITH AZATHIOPRINE FOR CROHN'S DISEASE. A SINGLE CENTRE EXPERIENCE 147
LONG TERM FUNCTIONAL RESULTS AND QUALITY OF LIFE AFTER RESTORATIVE PROCTOCOLECTOMY FOR ULCERATIVE COLITIS: A TWENTY YEARS EXPERIENCE 147
Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission: a predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials 146
Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression. 146
M1085 Use of Infliximab and Adalimumab in Refractory Pouchitis 145
Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients 145
Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study. 144
Probiotic therapy to prevent pouchitis onset 144
TREATMENT OF PERIANAL CROHN'S DISEASE WITH COMBINED SURGICAL AND BIOLOGICAL THERAPY 143
The effects of probiotic bacteria on spontaneous contraction of isolated guinea-pig intestine 141
LONG TERM FUNCTIONAL RESULTS AND QUALITY OF LIFE AFTER RESTORATIVE PROCTOCOLECTOMY FOR ULCERATIVE COLITIS: A TWENTY YEARS EXPERIENCE 140
p-ANCA and development of pouchitis in ulcerative colitis patients after proctocolectomy and ileoanal pouch anastomosis 134
Effects of probiotic bacteria on gastrointestinal motility in guinea-pig isolated tissue 133
Totale 20.490
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.700
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.700
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.520 0 0 172 138 213 106 65 124 262 228 806 406
2022/20233.471 379 509 198 413 198 294 82 199 666 81 229 223
2023/2024989 69 147 92 77 98 272 46 51 21 61 27 28
2024/20253.291 176 490 291 218 649 158 207 111 41 219 95 636
2025/20268.267 913 626 666 532 903 524 777 249 1.833 700 251 293
2026/20271.431 351 445 635 0 0 0 0 0 0 0 0 0
Totale 27.205